Cardinal Health

United States Medical Face Shields Market Insights 2024-2029: Emerging Med-tech Companies Pose a Considerable Threat to Global Players with their Innovative Products and Technologies - ResearchAndMarkets.com

Retrieved on: 
среда, июня 12, 2024
Medical Supplies, Health, PPE, Traction, MEDLINE, USD, Infection, Growth, Hospital, Ageing, Personal protective equipment, Personal, Cardinal Health, COVID-19, The

In 2023, the market was dominated by reusable face shields, accounting for a significant market share of more than 70%.

Key Points: 
  • In 2023, the market was dominated by reusable face shields, accounting for a significant market share of more than 70%.
  • However, the forecast period anticipates a shift as disposable face shields gain traction due to their affordability and convenience.
  • Disposable face shields are increasingly preferred because they prevent direct contact with respiratory droplets, crucial in mitigating the spread of infectious diseases.
  • Emerging med-tech companies pose a considerable threat to global players with their innovative products and technologies.

Craig Morford to Retire as Vice President, General Counsel and Secretary; Jeff Taylor Elected as Vice President, General Counsel and Secretary

Retrieved on: 
среда, июня 12, 2024
Oil, Gas, Energy, Multimedia, Retirement, History, Raytheon Missiles & Defense, Counsel, General Motors, Justice, Cardinal Health, Harvard Law School, XOM, ExxonMobil, General counsel, Fox Corporation, Stanford University, Federation, Management

Craig Morford, Vice President, General Counsel and Secretary for Exxon Mobil Corporation (NYSE: XOM), has announced his retirement effective July 1, 2024.

Key Points: 
  • Craig Morford, Vice President, General Counsel and Secretary for Exxon Mobil Corporation (NYSE: XOM), has announced his retirement effective July 1, 2024.
  • The Board of Directors has elected Jeff Taylor as Vice President, General Counsel and Secretary for the company.
  • Taylor joined ExxonMobil in May 2024 from Fox Corporation, where he was Executive Vice President and General Counsel.
  • Before joining Fox, Taylor served as Deputy General Counsel and Chief Compliance Officer for General Motors Co., and as the General Counsel of Raytheon Integrated Defense Systems.

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Retrieved on: 
пятница, мая 17, 2024
Conference call, UCL, Cardinal Health, Marketing, European Medicines Agency, CD19, FDA, EHA, Multiple myeloma, GD2, Immunotherapy, Research, Flow cytometry, Information technology, University College London, Cardinal, SLE, Conference, BioNTech, MIA, ACS Chemical Biology, MAA, ASH, Clinical trial, Bone marrow, Trial of the century, Nucleus, ADS, ASCO, SME, Minocycline, Marketing Authorisation Application, BCMA, Society, European Hematology Association, Canadian Aviation Regulations, Patient, Nature Communications, T cell, Quarter, Therapy, Engineering, Autoimmune disease, PDUFA, ALL, EMA, TRBC, Abstract, BLA, GMP

Two patients have been enrolled and Autolus continues to expect initial clinical data in late 2024.

Key Points: 
  • Two patients have been enrolled and Autolus continues to expect initial clinical data in late 2024.
  • Enrollment of the initial cohorts are complete and further updates from the MCARTY study are anticipated in H2 2024.
  • In April 2024, Autolus announced the appointment of Mike Bonney as Chairman of the Board, and Ravi Rao M.D., as Non-Executive Director.
  • Financial Results for the Quarter Ended March 31, 2024

Pristine Surgical Announces the Addition of Christopher Cleary to its Board of Directors

Retrieved on: 
вторник, мая 21, 2024
Medical Devices, Health, Technology, Surgery, Health Technology, Software, Patient, Cardinal Health, Investment, Endoscopy, Sale, Senior, Growth, Acquisition, GE Capital, Physician, Corporate development, Medtronic, Multimedia, Chris, Management

Pristine Surgical , a medical device company dedicated to simplifying endoscopy with its 4K single-use digital arthroscopes, today announced the addition of Christopher Cleary to its Board of Directors.

Key Points: 
  • Pristine Surgical , a medical device company dedicated to simplifying endoscopy with its 4K single-use digital arthroscopes, today announced the addition of Christopher Cleary to its Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20240521539345/en/
    Chris Cleary Joins Pristine Surgical Board of Directors (Photo: Business Wire)
    "We are thrilled to welcome Chris to the Board of Directors.
  • “His leadership and vision will be instrumental in guiding Pristine Surgical through its next phase of growth and innovation."
  • "I am incredibly excited to join the Board of Directors at Pristine Surgical.

IntelliGuard Appoints Seasoned Leader as New Chief Product Officer for Enhanced Healthcare Solutions

Retrieved on: 
среда, мая 15, 2024
Technology, Surgery, Hospitals, Health Technology, Practice Management, Pharmaceutical, Health, Data Management, Supply Chain Management, Retail, ARC, Patient, Strategic planning, Environment, Cardinal Health, Knowledge, CareFusion, Safety, Multimedia, Marketing, Management

IntelliGuard , a fast-growing provider of medication management and data intelligence solutions, announces the appointment of Rob Sobie as Chief Product Officer.

Key Points: 
  • IntelliGuard , a fast-growing provider of medication management and data intelligence solutions, announces the appointment of Rob Sobie as Chief Product Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240515332383/en/
    Rob brings a wealth of knowledge, boasting an impressive three-decade tenure in product development, strategic planning, and executive leadership within the healthcare sector.
  • In his role as Chief Product Officer, Rob will be responsible for overseeing all aspects of product management, from conceptualization to execution.
  • I look forward to playing a pivotal role in this journey and driving forward our shared vision for a safer, more efficient healthcare system.”

$20+ Billion Advanced Wound Care Market Trends and Global Forecasts 2024-2035: Smart Bandages and AI Integration Revolutionizing Advanced Wound Care Solutions - ResearchAndMarkets.com

Retrieved on: 
вторник, мая 14, 2024
Medical Supplies, Health, Wound healing, Partnership, Cardinal Health, USD, Type, Machine learning, Prevalence, Conditional sentence, Infection, Mouth ulcer, AI, Growth, Convatec, BD (company), Medicare, Nursing

The "Advanced Wound Care Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Advanced Wound Care Dressing, Type of Acute Wound Treated, Type of End User, Leading Advanced Wound Care Manufacturers, and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Advanced Wound Care Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Advanced Wound Care Dressing, Type of Acute Wound Treated, Type of End User, Leading Advanced Wound Care Manufacturers, and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.
  • These factors have, subsequently, prompted the innovators to develop innovative and technologically advanced wound care products for effective wound care management.
  • Advanced wound care products / advanced wound care management solutions refer to a group of products that can be utilized by the healthcare professionals to expedite the healing process of a wound.
  • Notably, over the past three years, close to 100 partnerships have been established by stakeholders in advanced wound care market.

Genstar Names Keith Martino to Strategic Advisory Board

Retrieved on: 
вторник, апреля 30, 2024
University, David G. Booth, Investment, SAB, Pharma, AbbVie, Central Waqf Council, Health, Cardinal Health, Partnership, Business, Genstar Capital, Genstar, SAN, Management

SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board. He will advise the Genstar team in its healthcare vertical.

Key Points: 
  • SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board.
  • Scott Niehaus, Director of Genstar Capital, said, "Keith is highly regarded in the pharma industry and has extensive background across the value chain including working with private equity.
  • We look forward to Keith's guidance in evaluating new healthcare investment opportunities and advising portfolio companies as a board member."
  • Mr. Martino was named to the Board of Genstar portfolio company Signant Health.

FDA Roundup: April 26, 2024

Retrieved on: 
пятница, апреля 26, 2024
FDA, Lutetium (177Lu) oxodotreotide, Sale, Answer, Public, Report, Cosmetics, Syringe, Dietary supplement, News, Safety, DCM, Food, Research, Human services, GFI, Animal, Dilated cardiomyopathy, Cardinal Health, Commitment, Diabetes, Furosemide, Glomus tumor, Vaccine, Development, VFD, Osteoporosis, Novartis, BRAF, Inflammatory bowel disease, Tablet, Patient, Rheumatoid arthritis, Psoriasis, Heated tobacco product, Macular degeneration, Multimedia, Dog, Cancer, LGG, Food and Drug Administration, BRAF V600, Heart, Pharmaceutical industry

On Thursday, the FDA announced it has approved the first generic pimobendan for the management of congestive heart failure in dogs.

Key Points: 
  • On Thursday, the FDA announced it has approved the first generic pimobendan for the management of congestive heart failure in dogs.
  • The FDA expects this firm to fully address the violations described in the warning letter.
  • This represents the first FDA approval of a radioactive drug, or radiopharmaceutical, for pediatric patients 12 years of age and older with SSTR-positive GEP-NETs.
  • This represents the first FDA approval of a systemic therapy for the treatment of patients with pediatric LGG with BRAF rearrangements, including fusions.

Ilant Health Extends Seed Round to $5.5 Million, Attracting New Investors and Accelerating Growth

Retrieved on: 
среда, апреля 17, 2024
Health, Health Technology, Practice Management, Fitness & Nutrition, General Health, Cardiology, Pillar, Highmark, Traction, Jess, Capital, Woman, Cardinal Health, Machine learning, Allegheny Health Network, Harvard Business School, Attention, NPS, Obesity, HPIR, Physician, Tenet Healthcare, Partner

Ilant Health , a pioneering leader in value-based obesity management and cardiometabolic health solutions, announced today the extension of its seed round of fundraising from $3 million to $5.5 million.

Key Points: 
  • Ilant Health , a pioneering leader in value-based obesity management and cardiometabolic health solutions, announced today the extension of its seed round of fundraising from $3 million to $5.5 million.
  • The decision to extend the seed round comes on the heels of Ilant’s accelerating traction due to its robust clinical model and proprietary analytics.
  • Notably, Ilant Health has garnered significant recognition, winning all three World 50 Group Academies — EHIR, HPIR, and PHIR, — and being selected for Highmark and Allegheny Health Network's accelerator, AlphaLab Health.
  • "AlphaLab Health looks for companies to solve problems facing healthcare today,” said Dr. Jeffrey Cohen, Chief Physician Executive at Allegheny Health Network.

AdaptHealth Appoints Suzanne Foster as Chief Executive Officer

Retrieved on: 
среда, апреля 17, 2024
Nursing, Medical Supplies, Health, Medical Devices, Practice Management, Managed Care, Cardiology, Health policy, Danaher Corporation, Chairperson, Cardinal Health, Diabetes, History, Obesity, JD, Sleep apnea, Suffolk University Law School, Stanley Black & Decker, Harvard University, Growth, Management

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer.

Key Points: 
  • AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer.
  • Ms. Foster will assume leadership of the Company from interim CEO and Chairman of the Board, Richard Barasch, on May 20, 2024.
  • Ms. Foster holds an MPH in Law and Health Policy from Harvard University and a JD from Suffolk University Law School.
  • We are grateful for his dedication to AdaptHealth and know he is delivering a healthy business to Suzanne.